$SSOK
Sunstock, Inc.

2024 Q3 Form 10-Q Financial Statement

#000149315224033399 Filed on August 21, 2024

View on sec.gov

Income Statement

Concept 2024 Q3 2024 Q2
Revenue $2.999M $3.007M
YoY Change -0.16% -4.8%
Cost Of Revenue $2.845M $2.813M
YoY Change -4.26% -9.96%
Gross Profit $153.5K $193.7K
YoY Change 386.55% 466.6%
Gross Profit Margin 5.12% 6.44%
Selling, General & Admin $54.17K
YoY Change 167.77%
% of Gross Profit 27.96%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $55.00 $55.00
YoY Change 0.0% 0.0%
% of Gross Profit 0.04% 0.03%
Operating Expenses $26.99K $61.45K
YoY Change -73.04% 115.89%
Operating Profit $126.5K $132.3K
YoY Change -284.49% 2209.22%
Interest Expense $129.2K
YoY Change -402.93%
% of Operating Profit 97.65%
Other Income/Expense, Net $74.45K $129.2K
YoY Change -421.47% -177.7%
Pretax Income $201.0K $261.4K
YoY Change -319.07% -262.88%
Income Tax
% Of Pretax Income
Net Earnings $201.0K $261.4K
YoY Change -319.07% -262.88%
Net Earnings / Revenue 6.7% 8.7%
Basic Earnings Per Share $0.04 $0.05
Diluted Earnings Per Share $0.04 $0.05
COMMON SHARES
Basic Shares Outstanding 5.022M shares 5.022M shares
Diluted Shares Outstanding 5.258M shares 5.022M shares

Balance Sheet

Concept 2024 Q3 2024 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $5.680K
YoY Change -42.51%
Cash & Equivalents $15.76K $5.682K
Short-Term Investments
Other Short-Term Assets $21.01K
YoY Change 18.37%
Inventory $2.457M
Prepaid Expenses $11.17K $21.01K
Receivables
Other Receivables
Total Short-Term Assets $2.703M $2.484M
YoY Change 47.78% 36.06%
LONG-TERM ASSETS
Property, Plant & Equipment $36.00 $92.00
YoY Change -86.05% -70.61%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $24.24K $28.65K
YoY Change 1340.46% 805.63%
TOTAL ASSETS
Total Short-Term Assets $2.703M $2.484M
Total Long-Term Assets $24.24K $28.65K
Total Assets $2.727M $2.513M
YoY Change 48.97% 37.39%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable
YoY Change
Accrued Expenses $584.4K
YoY Change 29.78%
Deferred Revenue
YoY Change
Short-Term Debt $99.24K
YoY Change
Long-Term Debt Due $2.570K
YoY Change -61.58%
Total Short-Term Liabilities $601.4K $722.5K
YoY Change 2.37% 46.47%
LONG-TERM LIABILITIES
Long-Term Debt $147.2K
YoY Change 2.72%
Other Long-Term Liabilities $9.880K
YoY Change
Total Long-Term Liabilities $157.1K
YoY Change 9.62%
TOTAL LIABILITIES
Total Short-Term Liabilities $601.4K $722.5K
Total Long-Term Liabilities $157.1K
Total Liabilities $753.0K $879.6K
YoY Change 3.15% 38.17%
SHAREHOLDERS EQUITY
Retained Earnings -$65.45M -$65.65M
YoY Change -1.11% -0.67%
Common Stock $611.00 $502.00
YoY Change 21.71% 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $1.974M $1.633M
YoY Change
Total Liabilities & Shareholders Equity $2.727M $2.513M
YoY Change 48.97% 37.39%

Cashflow Statement

Concept 2024 Q3 2024 Q2
OPERATING ACTIVITIES
Net Income $201.0K $261.4K
YoY Change -319.07% -262.88%
Depreciation, Depletion And Amortization $55.00 $55.00
YoY Change 0.0% 0.0%
Cash From Operating Activities -$25.95K
YoY Change -12.74%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 25.86K
YoY Change -26.07%
NET CHANGE
Cash From Operating Activities -25.95K
Cash From Investing Activities
Cash From Financing Activities 25.86K
Net Change In Cash -90.00
YoY Change -101.72%
FREE CASH FLOW
Cash From Operating Activities -$25.95K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2024Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
CY2023Q4 us-gaap Preferred Stock Value
PreferredStockValue
usd
dei Document Type
DocumentType
10-Q
CY2024Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
129172 usd
CY2024Q2 us-gaap Preferred Stock Value
PreferredStockValue
usd
dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2024Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
5682 usd
CY2024Q2 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
21013 usd
CY2024Q2 us-gaap Assets Current
AssetsCurrent
2484058 usd
CY2024Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
28562 usd
CY2024Q2 us-gaap Assets
Assets
2512712 usd
CY2024Q2 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
602031 usd
CY2024Q2 us-gaap Loans Payable To Bank Current
LoansPayableToBankCurrent
2570 usd
CY2024Q2 us-gaap Long Term Loans Payable
LongTermLoansPayable
147211 usd
CY2024Q2 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
9879 usd
CY2024Q2 us-gaap Liabilities
Liabilities
879609 usd
CY2024Q2 us-gaap Common Stock Value
CommonStockValue
502 usd
CY2024Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
67279869 usd
CY2024Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-65647268 usd
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
1633103 usd
CY2024Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
2512712 usd
CY2024Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
3006739 usd
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Entity Central Index Key
EntityCentralIndexKey
0001559157
CY2024Q2 SSOK Loss On Settlement Of Related Party Debt
LossOnSettlementOfRelatedPartyDebt
usd
SSOK Loss On Settlement Of Related Party Debt
LossOnSettlementOfRelatedPartyDebt
usd
CY2023Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
SSOK Loss On Settlement Of Related Party Debt
LossOnSettlementOfRelatedPartyDebt
usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
usd
us-gaap Payments Of Loan Costs
PaymentsOfLoanCosts
usd
us-gaap Interest Paid Net
InterestPaidNet
usd
us-gaap Interest Paid Net
InterestPaidNet
usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
usd
us-gaap Stock Issued1
StockIssued1
usd
dei Document Period End Date
DocumentPeriodEndDate
2024-06-30
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
000-54830
dei Entity Registrant Name
EntityRegistrantName
SUNSTOCK, INC.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
46-1856372
dei Entity Address Address Line1
EntityAddressAddressLine1
111 Vista Creek Circle
dei Entity Address City Or Town
EntityAddressCityOrTown
Sacramento
dei Entity Address State Or Province
EntityAddressStateOrProvince
CA
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
95835
dei City Area Code
CityAreaCode
916
dei Local Phone Number
LocalPhoneNumber
860-9622
dei Security12b Title
Security12bTitle
Common Stock.
dei Trading Symbol
TradingSymbol
SSOK.
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
dei Entity Listing Par Value Per Share
EntityListingParValuePerShare
0.0001
CY2024Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
5021857 shares
CY2023Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
9327 usd
CY2023Q4 us-gaap Assets Current
AssetsCurrent
2110690 usd
CY2024Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
92 usd
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
203 usd
CY2023Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
37120 usd
CY2023Q4 us-gaap Assets
Assets
2148013 usd
CY2023Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
564933 usd
CY2023Q4 us-gaap Loans Payable To Bank Current
LoansPayableToBankCurrent
8368 usd
CY2024Q2 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
18683 usd
CY2023Q4 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
16233 usd
CY2024Q2 us-gaap Liabilities Current
LiabilitiesCurrent
722519 usd
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
615215 usd
CY2023Q4 us-gaap Long Term Loans Payable
LongTermLoansPayable
141632 usd
CY2023Q4 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
20887 usd
CY2023Q4 us-gaap Liabilities
Liabilities
777734 usd
CY2024Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2023Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2024Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
20000000 shares
CY2023Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
20000000 shares
CY2024Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2024Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2024Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2024Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2024Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
5021857 shares
CY2024Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
5021857 shares
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
502 usd
CY2023Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
67279869 usd
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-65910092 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
1370279 usd
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
2148013 usd
CY2023Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
3158247 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
3288877 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
6498131 usd
CY2024Q2 us-gaap Cost Of Revenue
CostOfRevenue
2813020 usd
CY2023Q2 us-gaap Cost Of Revenue
CostOfRevenue
3124057 usd
us-gaap Cost Of Revenue
CostOfRevenue
3091505 usd
us-gaap Cost Of Revenue
CostOfRevenue
6417450 usd
CY2024Q2 us-gaap Gross Profit
GrossProfit
193719 usd
CY2023Q2 us-gaap Gross Profit
GrossProfit
34190 usd
us-gaap Gross Profit
GrossProfit
197372 usd
us-gaap Gross Profit
GrossProfit
80681 usd
CY2024Q2 us-gaap Professional Fees
ProfessionalFees
54174 usd
CY2023Q2 us-gaap Professional Fees
ProfessionalFees
20229 usd
us-gaap Professional Fees
ProfessionalFees
97580 usd
us-gaap Professional Fees
ProfessionalFees
82281 usd
CY2024Q2 us-gaap Other Expenses
OtherExpenses
7273 usd
CY2023Q2 us-gaap Other Expenses
OtherExpenses
8233 usd
us-gaap Other Expenses
OtherExpenses
12235 usd
us-gaap Other Expenses
OtherExpenses
16481 usd
CY2024Q2 us-gaap Operating Expenses
OperatingExpenses
61447 usd
CY2023Q2 us-gaap Operating Expenses
OperatingExpenses
28462 usd
us-gaap Operating Expenses
OperatingExpenses
109815 usd
us-gaap Operating Expenses
OperatingExpenses
98762 usd
CY2024Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
132272 usd
CY2023Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
5728 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
87557 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-18081 usd
CY2024Q2 us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
131920 usd
CY2023Q2 us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
-40051 usd
us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
180084 usd
us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
-25976 usd
CY2024Q2 us-gaap Interest Expense Nonoperating
InterestExpenseNonoperating
1371 usd
CY2023Q2 us-gaap Interest Expense Nonoperating
InterestExpenseNonoperating
1443 usd
us-gaap Interest Expense Nonoperating
InterestExpenseNonoperating
2814 usd
us-gaap Interest Expense Nonoperating
InterestExpenseNonoperating
2886 usd
CY2024Q2 SSOK Interest Expenses Related Party
InterestExpensesRelatedParty
1377 usd
CY2023Q2 SSOK Interest Expenses Related Party
InterestExpensesRelatedParty
1145 usd
SSOK Interest Expenses Related Party
InterestExpensesRelatedParty
2003 usd
SSOK Interest Expenses Related Party
InterestExpensesRelatedParty
1614 usd
CY2023Q2 SSOK Loss On Settlement Of Related Party Debt
LossOnSettlementOfRelatedPartyDebt
123600 usd
SSOK Loss On Settlement Of Related Party Debt
LossOnSettlementOfRelatedPartyDebt
123600 usd
CY2023Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-166239 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
175267 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-154076 usd
CY2024Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
261444 usd
CY2023Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-160511 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
262824 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-172157 usd
CY2024Q2 us-gaap Net Income Loss
NetIncomeLoss
261444 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-160511 usd
us-gaap Net Income Loss
NetIncomeLoss
262824 usd
us-gaap Net Income Loss
NetIncomeLoss
-172157 usd
CY2024Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.05
CY2024Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.05
CY2023Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.03
CY2023Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.03
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.05
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.05
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.04
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.04
CY2024Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
5021857 shares
CY2024Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
5021857 shares
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
4836231 shares
CY2023Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
4836231 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
5021857 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
5021857 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
4826100 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
4826100 shares
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
1137792 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-11646 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
1126146 usd
CY2023Q2 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
226601 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-160511 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
1192236 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
1370279 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
1380 usd
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
1371659 usd
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
1371659 usd
CY2024Q2 us-gaap Net Income Loss
NetIncomeLoss
261444 usd
CY2024Q2 us-gaap Net Income Loss
NetIncomeLoss
261444 usd
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
1633103 usd
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
1633103 usd
us-gaap Net Income Loss
NetIncomeLoss
262824 usd
us-gaap Net Income Loss
NetIncomeLoss
-172157 usd
us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
180084 usd
us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
-25976 usd
us-gaap Depreciation
Depreciation
111 usd
us-gaap Depreciation
Depreciation
111 usd
SSOK Loss On Settlement Of Related Party Debt
LossOnSettlementOfRelatedPartyDebt
123600 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
189706 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
72359 usd
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
11686 usd
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
12597 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
37098 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
9139 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-81443 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-98287 usd
us-gaap Payments Of Loan Costs
PaymentsOfLoanCosts
219 usd
us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
73554 usd
us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
91480 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
73335 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
91480 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-8108 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-6807 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
13790 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
16691 usd
CY2024Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
5682 usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
9884 usd
us-gaap Stock Issued1
StockIssued1
103000 usd
us-gaap Use Of Estimates
UseOfEstimates
<p id="xdx_841_eus-gaap--UseOfEstimates_zNBo6N66Iqvc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_86C_zCt9azRaH4J9">USE OF ESTIMATES</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of the unaudited condensed and consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. Significant estimates made by the Company’s management include realizability and valuation of inventories and value of stock-based transactions.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p>
us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p id="xdx_84F_eus-gaap--ConcentrationRiskCreditRisk_zgB4LlCGCzH2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_864_zzUDM0EETKe8">CONCENTRATION OF RISK</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Financial instruments that potentially subject the Company to concentrations of credit risk consist principally of cash. The Company places its cash with high quality banking institutions. The Company did not have cash balances in excess of the Federal Deposit Insurance Corporation limit as of June 30, 2024 and December 31, 2023.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2024Q2 us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
131920 usd
CY2023Q2 us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
-40051 usd
us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
180084 usd
us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
-25976 usd
us-gaap Asset Impairment Charges
AssetImpairmentCharges
0 usd
us-gaap Asset Impairment Charges
AssetImpairmentCharges
0 usd
CY2024Q2 us-gaap Income Tax Examination Penalties And Interest Accrued
IncomeTaxExaminationPenaltiesAndInterestAccrued
0 usd
CY2023Q4 us-gaap Income Tax Examination Penalties And Interest Accrued
IncomeTaxExaminationPenaltiesAndInterestAccrued
0 usd
CY2024Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-65647268 usd
CY2024Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
58460 usd
CY2023Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
58460 usd
CY2024Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
58368 usd
CY2023Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
58257 usd
CY2024Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
92 usd
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
203 usd
CY2024Q2 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
55 usd
CY2023Q2 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
55 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
111 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
111 usd
CY2024Q2 SSOK Accrued Court Decision Current
AccruedCourtDecisionCurrent
338171 usd
CY2023Q4 SSOK Accrued Court Decision Current
AccruedCourtDecisionCurrent
338171 usd
CY2024Q2 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
133981 usd
CY2023Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
133649 usd
CY2024Q2 SSOK Accrued Audit Fees Current
AccruedAuditFeesCurrent
47002 usd
CY2023Q4 SSOK Accrued Audit Fees Current
AccruedAuditFeesCurrent
14934 usd
CY2024Q2 us-gaap Dividends Payable Current
DividendsPayableCurrent
36326 usd
CY2023Q4 us-gaap Dividends Payable Current
DividendsPayableCurrent
36326 usd
CY2024Q2 us-gaap Interest Payable Current
InterestPayableCurrent
23022 usd
CY2023Q4 us-gaap Interest Payable Current
InterestPayableCurrent
20208 usd
CY2024Q2 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
8800 usd
CY2023Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
8919 usd
CY2024Q2 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
602031 usd
CY2023Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
564933 usd
CY2024Q2 us-gaap Dividends Payable Current
DividendsPayableCurrent
36326 usd
CY2024Q2 SSOK Percentage Used In Calculation Of Right Of Use Asset And Liability
PercentageUsedInCalculationOfRightOfUseAssetAndLiability
0.0495 pure
CY2023Q3 SSOK Lawsuit Judgement
LawsuitJudgement
77863 usd
CY2024Q2 us-gaap Long Term Debt Maturities Repayments Of Principal Remainder Of Fiscal Year
LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear
2454 usd
CY2024Q2 us-gaap Long Term Debt Maturities Repayments Of Principal In Next Twelve Months
LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
8940 usd
CY2024Q2 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Two
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
8940 usd
CY2024Q2 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Three
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
8940 usd
CY2024Q2 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Four
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour
8940 usd
CY2024Q2 SSOK Long Term Debt Maturities Repayments Of Principal After Year Four
LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFour
211163 usd
CY2024Q2 us-gaap Long Term Debt
LongTermDebt
249377 usd
CY2024Q2 us-gaap Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
99596 usd
CY2024Q2 us-gaap Loans Payable
LoansPayable
149781 usd
CY2024Q2 us-gaap Loans Payable Current
LoansPayableCurrent
2570 usd
CY2024Q2 us-gaap Long Term Loans Payable
LongTermLoansPayable
147211 usd
SSOK Weighted Average Remaining Loan Term
WeightedAverageRemainingLoanTerm
P28Y4M24D
CY2024Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2024Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
20000000 shares
us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
0 shares

Files In Submission

Name View Source Status
0001493152-24-033399-index-headers.html Edgar Link pending
0001493152-24-033399-index.html Edgar Link pending
0001493152-24-033399.txt Edgar Link pending
0001493152-24-033399-xbrl.zip Edgar Link pending
ex31-1.htm Edgar Link pending
ex32-1.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
form10-q.htm Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
form10-q_htm.xml Edgar Link completed
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
ssok-20240630.xsd Edgar Link pending
ssok-20240630_lab.xml Edgar Link unprocessable
ssok-20240630_def.xml Edgar Link unprocessable
ssok-20240630_cal.xml Edgar Link unprocessable
ssok-20240630_pre.xml Edgar Link unprocessable